Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell function
about
Leukocyte Ig-Like Receptors - A Model for MHC Class I Disease AssociationsNK Cells in HIV DiseaseThe evolution of natural killer cell receptorsSuppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus PeptidesSelection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South AfricaHepatitis C Virus and Human Cytomegalovirus-Natural Killer Cell Subsets in Persistent Viral Infections.Influence of Glycosylation Inhibition on the Binding of KIR3DL1 to HLA-B*57:01.HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C∗12:02/C∗14:03Natural killer cell heterogeneity: cellular dysfunction and significance in HIV-1 immuno-pathogenesis.Innate immunity against HIV-1 infection.HIV-1 adaptation to NK cell-mediated immune pressure.Missing or altered self: human NK cell receptors that recognize HLA-C.KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques.Specificity of inhibitory KIRs enables NK cells to detect changes in an altered peptide environment.Peptide-specific engagement of the activating NK cell receptor KIR2DS1.Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function.Natural Killer cells in HIV-1 infection and therapy.Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection.Stable Frequencies of HLA-C03:04/Peptide-Binding KIR2DL2/3 Natural Killer Cells Following Vaccination
P2860
Q26738439-C78F7F52-8999-43C5-8342-A6D1E2793BFDQ26752833-554B604F-D971-4AA9-8CEB-0C2061E8D551Q26782592-82B3A49D-C94A-47DA-AE81-568E4C62C2F2Q27317377-A1C5EDF3-E196-4BF9-A49D-8814778224E3Q28607344-B624EDC8-E3E3-4D6C-BDB2-F2D6ADDD2FC8Q33694920-8DE78C9B-6203-4753-8C65-DA4DB28D016DQ35872389-17A89C0A-B342-41F6-9F01-9EABDE1AF629Q37532336-F83147BA-AA81-42AE-8185-3DABE2A0A9DAQ38457805-210CF378-AA79-4364-90D8-8D88D43C50EEQ38491184-E6E94758-A10D-4E71-83B0-D1C3D390AE5BQ38743267-63122678-CE82-43C9-8534-63480D513C94Q39427580-93E67356-6897-4610-A1BE-1FBA053C4812Q40122626-003292CB-AAF5-4240-B3B7-2D91B07B8817Q40127990-6535314F-14E1-4B7B-A5C7-0BEA7CDA6677Q40184605-3503C534-29C9-4A05-A25E-387D7A28DD0FQ40723325-A83876E4-35D9-40A6-917D-B01E5AE4C31FQ41934634-84C42D7E-9159-4E8E-AE49-FA517974B57BQ46722989-4B16ACE9-2CEA-46C6-BF63-B1C475E94A48Q58606347-91A4DF92-B5E7-42E6-A4EC-5F5B96A7551B
P2860
Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell function
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Sequence variations in HIV-1 p ...... y natural killer cell function
@ast
Sequence variations in HIV-1 p ...... y natural killer cell function
@en
type
label
Sequence variations in HIV-1 p ...... y natural killer cell function
@ast
Sequence variations in HIV-1 p ...... y natural killer cell function
@en
prefLabel
Sequence variations in HIV-1 p ...... y natural killer cell function
@ast
Sequence variations in HIV-1 p ...... y natural killer cell function
@en
P2093
P2860
P50
P1433
P1476
Sequence variations in HIV-1 p ...... y natural killer cell function
@en
P2093
Angelique Hölzemer
David T Evans
Debbie van Baarle
Jamie L Schafer
Lena Fadda
Nienke H van Teijlingen
Todd J Suscovich
Wilfredo F García-Beltrán
P2860
P304
P356
10.1097/QAD.0000000000000284
P407
P577
2014-06-01T00:00:00Z